✦ LIBER ✦

Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB2 Agonist for the Treatment of Chronic Pain

✍ Scribed by Giblin, Gerard M. P.; Billinton, Andrew; Briggs, Michael; Brown, Andrew J.; Chessell, Iain P.; Clayton, Nick M.; Eatherton, Andrew J.; Goldsmith, Paul; Haslam, Carl; Johnson, Matthew R.

Book ID: 111645496
Publisher: American Chemical Society
Year: 2009
Tongue: English
Weight: 769 KB
Volume: 52
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm9009857

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of 4-(2-(4-Amino-1,2,5-ox

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

✍ Rhodes, Nelson; Leber, Jack D.; Clark, Tammy J.; Keenan, Richard M.; Lafrance, L 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 886 KB

Inverse agonist properties of N-(piperid

Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor

✍ Justin P. Meschler; Dennis M. Kraichely; Gerald H. Wilken; Allyn C. Howlett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Discovery of N -[(1 S ,2 S )-3-(4-Chloro

Discovery of N -[(1 S ,2 S )-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

✍ Lin, Linus S.; Lanza,, Thomas J.; Jewell, James P.; Liu, Ping; Shah, Shrenik K.; 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 85 KB

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)- N -(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1 H -pyrazole-4-carboxamide (AMG 458)

✍ Liu, Longbin; Siegmund, Aaron; Xi, Ning; Kaplan-Lefko, Paula; Rex, Karen; Chen, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 191 KB

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

Discovery and Structure−Activity Relatio

Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of Obesity

✍ Smith, Brian M.; Smith, Jeffrey M.; Tsai, James H.; Schultz, Jeffrey A.; Gilson, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 154 KB